Tandem Diabetes Care
TNDM
TNDM
265 hedge funds and large institutions have $2.98B invested in Tandem Diabetes Care in 2019 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 80 increasing their positions, 81 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
265
Holders Change
+65
Holders Change %
+32.5%
% of All Funds
5.74%
Holding in Top 10
12
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+71.43%
% of All Funds
0.26%
New
83
Increased
80
Reduced
81
Closed
15
Calls
$84.5M
Puts
$54M
Net Calls
+$30.5M
Net Calls Change
+$13.1M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$91.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
$44.8M |
| 3 |
D.E. Shaw & Co
New York
|
$33M |
| 4 |
GGHC
Gilder Gagnon Howe & Co
New York
|
$34.1M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
$26.1M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$7.76M |
| 2 |
Renaissance Technologies
New York
|
$49.2M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$30.3M |
| 4 |
FAM
Fred Alger Management
New York
|
$168M |
| 5 |
DM
Deerfield Management
New York
|
$2.25M |
